The FDA-approved smoking cessation pill, varenicline, is emerging as a powerful ally in the battle against nicotine addiction, especially among teens and young adults grappling with vaping.Recent clinical trials have shown that this twice-daily medication significantly increases the chances of quitting for this vulnerable demographic, offering a new hope for those struggling to break free from their vaping habits.